The objective and reliable quantification of adenoid size is pivotal for precise clinical diagnosis and the formulation of effective treatment strategies. Conventional manual measurement techniques, however, are often labor-intensive and time-consuming. To develop and validate a fully automated system for measuring adenoid size using deep learning (DL) on lateral head and neck radiographs. In this retrospective study, we analyzed 711 lateral head and neck radiographs collected from two centers between February and July 2023. A DL-based adenoid size measurement system was developed, utilizing Fujioka's method. The system employed the RTMDet network and RTMPose networks for accurate landmark detection, and mathematical formulas were applied to determine adenoid size. To evaluate consistency and reliability of the system, we employed the intra-class correlation coefficient (ICC), mean absolute difference (MAD), and Bland-Altman plots as key assessment metrics. The DL-based system exhibited high reliability in the prediction of adenoid, nasopharynx, and adenoid-nasopharyngeal ratio measurements, showcasing strong agreement with the reference standard. The results indicated an ICC for adenoid measurements of 0.902 [95%CI, 0.872-0.925], with a MAD of 1.189 and a root mean square (RMS) of 1.974. For nasopharynx measurements, the ICC was 0.868 [95%CI, 0.828-0.899], with a MAD of 1.671 and an RMS of 1.916. Additionally, the adenoid-nasopharyngeal ratio measurements yielded an ICC of 0.911 [95%CI, 0.883-0.932], a MAD of 0.054, and an RMS of 0.076. The developed DL-based system effectively automates the measurement of the adenoid-nasopharyngeal ratio, adenoid, and nasopharynx on lateral neck or head radiographs, showcasing high reliability.

Retrospective study. To develop a deep learning (DL) model to predict bone cement leakage (BCL) subtypes during percutaneous kyphoplasty (PKP) using preoperative computed tomography (CT) as well as employing multicenter data to evaluate the effectiveness and generalizability of the model. DL excels at automatically extracting features from medical images. However, there is a lack of models that can predict BCL subtypes based on preoperative images. This study included an internal dataset for DL model training, validation, and testing as well as an external dataset for additional model testing. Our model integrated a segment localization module based on vertebral segmentation via three-dimensional (3D) U-Net with a classification module based on 3D ResNet-50. Vertebral level mismatch rates were calculated, and confusion matrixes were used to compare the performance of the DL model with that of spine surgeons in predicting BCL subtypes. Furthermore, the simple Cohen's kappa coefficient was used to assess the reliability of spine surgeons and the DL model against the reference standard. A total of 901 patients containing 997 eligible segments were included in the internal dataset. The model demonstrated a vertebral segment identification accuracy of 96.9%. It also showed high area under the curve (AUC) values of 0.734-0.831 and sensitivities of 0.649-0.900 for BCL prediction in the internal dataset. Similar favorable AUC values of 0.709-0.818 and sensitivities of 0.706-0.857 were observed in the external dataset, indicating the stability and generalizability of the model. Moreover, the model outperformed nonexpert spine surgeons in predicting BCL subtypes, except for type II. The model achieved satisfactory accuracy, reliability, generalizability, and interpretability in predicting BCL subtypes, outperforming nonexpert spine surgeons. This study offers valuable insights for assessing osteoporotic vertebral compression fractures, thereby aiding preoperative surgical decision-making. 3.

Artificial intelligence (AI)-empowered data processing tools improve our ability to assess, measure, and enhance medical interventions. AI-based tools automate the extraction of data from histories, test results, imaging, prescriptions, and treatment outcomes, and transform them into unified, accessible records. They are powerful in converting unstructured data such as clinical notes, magnetic resonance images, and electroencephalograms into structured, actionable formats. For example, in the extraction and classification of diseases, symptoms, medications, treatments, and dates from even incomplete and fragmented clinical notes, pathology reports, images, and histological markers. Especially because the demographics within correctional facilities greatly diverge from the general population, the adoption of electronic health records and AI-enabled data processing will play a crucial role in improving disease detection, treatment management, and the overall efficiency of health care within prison systems.

Artificial intelligence (AI) models based on pathological slides have great potential to assist pathologists in disease diagnosis and have become an important research direction in the field of medical image analysis. The aim of this study was to develop an AI model based on whole-slide images to predict the stage of colon cancer. In this study, a total of 100 pathological slides of colon cancer patients were collected as the training set, and 421 pathological slides of colon cancer were downloaded from The Cancer Genome Atlas (TCGA) database as the external validation set. Cellprofiler and CLAM tools were used to extract pathological features, and machine learning algorithms and deep learning algorithms were used to construct prediction models. The area under the curve (AUC) of the best machine learning model was 0.78 in the internal test set and 0.68 in the external test set. The AUC of the deep learning model in the internal test set was 0.889, and the accuracy of the model was 0.854. The AUC of the deep learning model in the external test set was 0.700. The prediction model has the potential to generalize in the process of combining pathological omics diagnosis. Compared with machine learning, deep learning has higher recognition and accuracy of images, and the performance of the model is better.

Severity scores, which often refer to the likelihood or probability of a pathology, are commonly provided by artificial intelligence (AI) tools in radiology. However, little attention has been given to the use of these AI scores, and there is a lack of transparency into how they are generated. In this comment, we draw on key principles from psychological science and statistics to elucidate six human factors limitations of AI scores that undermine their utility: (1) variability across AI systems; (2) variability within AI systems; (3) variability between radiologists; (4) variability within radiologists; (5) unknown distribution of AI scores; and (6) perceptual challenges. We hypothesize that these limitations can be mitigated by providing the false discovery rate and false omission rate for each score as a threshold. We discuss how this hypothesis could be empirically tested. KEY POINTS: The radiologist-AI interaction has not been given sufficient attention. The utility of AI scores is limited by six key human factors limitations. We propose a hypothesis for how to mitigate these limitations by using false discovery rate and false omission rate.

This review paper comprehensively summarizes healthcare provider (HCP) evaluation of explanations produced by explainable artificial intelligence methods to support point-of-care, patient-specific, clinical decision-making (CDM) within medical settings. It highlights the critical need to incorporate human-centered (HCP) evaluation approaches based on their CDM needs, processes, and goals. The review was conducted in Ovid Medline and Scopus databases, following the Institute of Medicine's methodological standards and PRISMA guidelines. An individual study appraisal was conducted using design-specific appraisal tools. MaxQDA software was used for data extraction and evidence table procedures. Of the 2673 unique records retrieved, 25 records were included in the final sample. Studies were excluded if they did not meet this review's definitions of HCP evaluation (1156), healthcare use (995), explainable AI (211), and primary research (285), and if they were not available in English (1). The sample focused primarily on physicians and diagnostic imaging use cases and revealed wide-ranging evaluation measures. The synthesis of sampled studies suggests a potential common measure of clinical explainability with 3 indicators of interpretability, fidelity, and clinical value. There is an opportunity to extend the current model-centered evaluation approaches to incorporate human-centered metrics, supporting the transition into practice. Future research should aim to clarify and expand key concepts in HCP evaluation, propose a comprehensive evaluation model positioned in current theoretical knowledge, and develop a valid instrument to support comparisons.

This study investigates the effectiveness of U-Net architectures integrated with various convolutional neural network (CNN) backbones for automated lung cancer detection and segmentation in chest CT images, addressing the critical need for accurate diagnostic tools in clinical settings. A balanced dataset of 832 chest CT images (416 cancerous and 416 non-cancerous) was preprocessed using Contrast Limited Adaptive Histogram Equalization (CLAHE) and resized to 128x128 pixels. U-Net models were developed with three CNN backbones: ResNet50, VGG16, and Xception, to segment lung regions. After segmentation, CNN-based classifiers and hybrid models combining CNN feature extraction with traditional machine learning classifiers (Support Vector Machine, Random Forest, and Gradient Boosting) were evaluated using 5-fold cross-validation. Metrics included accuracy, precision, recall, F1-score, Dice coefficient, and ROC-AUC. U-Net with ResNet50 achieved the best performance for cancerous lungs (Dice: 0.9495, Accuracy: 0.9735), while U-Net with VGG16 performed best for non-cancerous segmentation (Dice: 0.9532, Accuracy: 0.9513). For classification, the CNN model using U-Net with Xception achieved 99.1 percent accuracy, 99.74 percent recall, and 99.42 percent F1-score. The hybrid CNN-SVM-Xception model achieved 96.7 percent accuracy and 97.88 percent F1-score. Compared to prior methods, our framework consistently outperformed existing models. In conclusion, combining U-Net with advanced CNN backbones provides a powerful method for both segmentation and classification of lung cancer in CT scans, supporting early diagnosis and clinical decision-making.

Objective: This study aims to support early diagnosis of Alzheimer's disease and detection of amyloid accumulation by leveraging the microstructural information available in multi-shell diffusion MRI (dMRI) data, using a vision transformer-based deep learning framework. Methods: We present a classification pipeline that employs the Swin Transformer, a hierarchical vision transformer model, on multi-shell dMRI data for the classification of Alzheimer's disease and amyloid presence. Key metrics from DTI and NODDI were extracted and projected onto 2D planes to enable transfer learning with ImageNet-pretrained models. To efficiently adapt the transformer to limited labeled neuroimaging data, we integrated Low-Rank Adaptation. We assessed the framework on diagnostic group prediction (cognitively normal, mild cognitive impairment, Alzheimer's disease dementia) and amyloid status classification. Results: The framework achieved competitive classification results within the scope of multi-shell dMRI-based features, with the best balanced accuracy of 95.2% for distinguishing cognitively normal individuals from those with Alzheimer's disease dementia using NODDI metrics. For amyloid detection, it reached 77.2% balanced accuracy in distinguishing amyloid-positive mild cognitive impairment/Alzheimer's disease dementia subjects from amyloid-negative cognitively normal subjects, and 67.9% for identifying amyloid-positive individuals among cognitively normal subjects. Grad-CAM-based explainability analysis identified clinically relevant brain regions, including the parahippocampal gyrus and hippocampus, as key contributors to model predictions. Conclusion: This study demonstrates the promise of diffusion MRI and transformer-based architectures for early detection of Alzheimer's disease and amyloid pathology, supporting biomarker-driven diagnostics in data-limited biomedical settings.

Brain tumor segmentation plays a critical role in clinical diagnosis and treatment planning, yet the variability in imaging quality across different MRI scanners presents significant challenges to model generalization. To address this, we propose the Edge Iterative MRI Lesion Localization System (EdgeIMLocSys), which integrates Continuous Learning from Human Feedback to adaptively fine-tune segmentation models based on clinician feedback, thereby enhancing robustness to scanner-specific imaging characteristics. Central to this system is the Graph-based Multi-Modal Interaction Lightweight Network for Brain Tumor Segmentation (GMLN-BTS), which employs a Modality-Aware Adaptive Encoder (M2AE) to extract multi-scale semantic features efficiently, and a Graph-based Multi-Modal Collaborative Interaction Module (G2MCIM) to model complementary cross-modal relationships via graph structures. Additionally, we introduce a novel Voxel Refinement UpSampling Module (VRUM) that synergistically combines linear interpolation and multi-scale transposed convolutions to suppress artifacts while preserving high-frequency details, improving segmentation boundary accuracy. Our proposed GMLN-BTS model achieves a Dice score of 85.1% on the BraTS2017 dataset with only 4.58 million parameters, representing a 98% reduction compared to mainstream 3D Transformer models, and significantly outperforms existing lightweight approaches. This work demonstrates a synergistic breakthrough in achieving high-accuracy, resource-efficient brain tumor segmentation suitable for deployment in resource-constrained clinical environments.

Precise segmentation of brain tumors from magnetic resonance imaging (MRI) is essential for neuro-oncology diagnosis and treatment planning. Despite advances in deep learning methods, automatic segmentation remains challenging due to tumor morphological heterogeneity and complex three-dimensional spatial relationships. Current techniques primarily rely on visual features extracted from MRI sequences while underutilizing semantic knowledge embedded in medical reports. This research presents a multi-level fusion architecture that integrates pixel-level, feature-level, and semantic-level information, facilitating comprehensive processing from low-level data to high-level concepts. The semantic-level fusion pathway combines the semantic understanding capabilities of Contrastive Language-Image Pre-training (CLIP) models with the spatial feature extraction advantages of 3D U-Net through three mechanisms: 3D-2D semantic bridging, cross-modal semantic guidance, and semantic-based attention mechanisms. Experimental validation on the BraTS 2020 dataset demonstrates that the proposed model achieves an overall Dice coefficient of 0.8567, representing a 4.8% improvement compared to traditional 3D U-Net, with a 7.3% Dice coefficient increase in the clinically important enhancing tumor (ET) region.